Publisher
Springer International Publishing
Reference82 articles.
1. Sinclair LI, Davies SJ, Parton G, Potokar JP (2010) Drug-drug interactions in general hospital and psychiatric hospital in-patients prescribed psychotropic medications. Int J Psychiatry Clin Pract 14:212–219
2. Ereshefsky L, Riesenman C, Lam YW (1996) Serotonin selective reuptake inhibitor drug interactions and the cytochrome P450 system. J Clin Psychiatry 57(Suppl 8):17–24; discussion 25
3. Alfaro CL, Lam YW, Simpson J, Ereshefsky L (1999) CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline. J Clin Psychopharmacol 19:155–163
4. Alfaro CL, Lam YW, Simpson J, Ereshefsky L (2000) CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations. J Clin Pharmacol 40:58–66
5. Nichols AI, Abell M, Chen Y, Behrle JA, Frick G, Paul J (2013) Effects of desvenlafaxine on the pharmacokinetics of desipramine in healthy adults. Int Clin Psychopharmacol 28:99–105